3rd Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Firm
Client
Income
—
Expenses
$760,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

S.3686 - Departments of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; S.3607 - Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisitions and stockpiling of biodefense vaccines; S.1649 and H.R. 5498 WMD Prevention and Preparedness Act of 2009 - all provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.

LobbyistCovered position, as disclosed
ASHLEY BRATICH —
CHRIS FRECH —
ALLEN SHOFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3607 (111th), S. 3686 (111th), H.R. 5498 (111th), S. 1649 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.